Mounjaro Weight Loss Program (Clinician Guided)

Rx
  • Fast Delivery
  • Muslim-Friendly
  • FDA Approved
  • Secure Payment
From RM53/month
  • 0% InterestNo interest on eligible instalments
  • Flexible paymentsSpread your payment across monthly instalments
  • No hidden feesClear and transparent pricing
🎟️ Available Vouchers
LOSS50
RM50 OFF
Min Spend RM1,000.00
Valid till: 30 Dec 2026

Click a voucher to copy the code. Automatically applied at checkout if conditions are met.

Prescription Required

Complete your checkout to get your prescription approved. A doctor will contact you within 30 minute(s) after payment.
Have questions? Chat with us on WhatsApp
Dr. Mohd Izzat Amir Bin Awang
Reviewed byDr. Mohd Izzat Amir Bin AwangDoctor of Medicine (MD), University of Mansoura - Manchester
Dr. Chong Zhan Pong
Written byDr. Chong Zhan PongDoctor of Medicine (MD), International Medical University (IMU)

Overview

Mounjaro Weight Loss Program (Clinician Guided) is a prescription-only medicine (POM) presented as a medicine, with Tirzepatide (active ingredient of Mounjaro) – strength and pen dispensed according to the individualised treatment plan as its active ingredient content.

This page is limited to product, safety and handling information, in line with Malaysian rules on prescription medicine information for the public. Your prescriber or pharmacist is the right source for anything beyond that, together with the leaflet inside the pack.

Through DoctorOnCall, this product is supplied after an online consultation with a licensed doctor and a valid prescription, and it is checked by a registered pharmacist before dispensing. Take it exactly as prescribed, and speak to your doctor before stopping, changing the dose, or starting any other medicine alongside it.

Directions for Use

Mounjaro is self-administered as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm, using a single-use pre-filled pen. As part of the programme, patients are guided on correct injection technique, injection-site rotation, and what to do if a dose is missed, in addition to receiving dietary and lifestyle guidance to support the treatment goal.

Dosage

Dosing under this programme follows the standard Mounjaro dose-titration schedule: treatment begins at a low starting dose and is increased gradually, typically every 4 weeks, up to an individualised maintenance dose, based on the patient’s response and tolerability. The exact starting dose, pace of titration, and target maintenance dose are determined and adjusted by the treating doctor as part of the programme – patients should never self-adjust their dose outside of this medical guidance.

Storage Instructions

Store unused pens in a refrigerator (2°C to 8°C); do not freeze. Once in use, follow the specific in-use storage duration and temperature stated in the product’s own packaging insert, and keep the pen out of reach of children and away from direct light and heat.

Side Effects

  • Nausea
  • Diarrhoea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Fatigue
  • Injection site reactions

Contraindications

  • Known hypersensitivity to the active ingredient or any component of the formulation
  • Personal or family history of medullary thyroid carcinoma
  • Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Pregnancy or breastfeeding, unless specifically advised otherwise by the treating doctor

Drug / Food Interactions

  • May increase the risk of low blood glucose when combined with insulin or sulfonylureas – relevant for patients with coexisting diabetes
  • Delayed gastric emptying may affect the absorption of other oral medicines, including oral contraceptives
  • Alcohol may worsen gastrointestinal side effects and is best limited during treatment
  • Inform your doctor of all prescription medicines, over-the-counter products, and supplements you are taking as part of your programme assessment

Quick Tips

  • Attend all scheduled follow-up consultations so your dose and progress can be reviewed
  • Keep a consistent weekly injection day and rotate injection sites
  • Follow the dietary and activity guidance given by your clinician alongside the medicine
  • Report persistent or severe side effects, such as ongoing vomiting or severe abdominal pain, to your care team promptly

Ingredients / Active Ingredients

  • Tirzepatide (active ingredient of Mounjaro) – strength and pen dispensed according to the individualised treatment plan

Safety Advice

Pregnancy

Limited Data

Limited information is available regarding use during pregnancy. Use only if clearly needed.

Breastfeeding

No Data

No data available regarding safety during breastfeeding.

Kidney

Use With Care

Use cautiously. Dose adjustment or monitoring may be required.

Liver

Use With Care

Use cautiously. Liver function monitoring may be required.

Alcohol

Use With Care

Caution is advised when consuming alcohol with this medicine.

Driving

Use With Care

Use caution while driving until you know how this medicine affects you.

Frequently Asked Questions

Product Specifications

BrandZuellig Pharma
ManufacturerZuellig Pharma
ClassificationPrescription medicine
Ingredients / Active IngredientsTirzepatide
Program10 mg (1 Month), 10 mg (3 Months), 10 mg (6 Months), 2.5 mg (3 Months), 2.5 mg (6 Months), 5 mg (3 Months), 5 mg (6 Months), 7.5 mg (1 Month), 7.5 mg (3 Months), 7.5 mg (6 Months)
Shelf LifeUse the dispensed pen before the expiry date stated on its packaging. Do not use the medicine if the expiry date has passed.

Customer Reviews

Be the first to review this product.

Confirm Action
×

Are you sure?

×